跳至主要内容
临床试验/NCT02554097
NCT02554097Unknown不适用

Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 2,700 人开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,700
试验地点
1
主要终点
Rate of Adverse outcomes

研究概览

简要总结

Patients with gallstone and confirmed common bile duct stones are registered in this study. The three managements for common bile duct stones are endoscopic sphincterotomy (EST), laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative investigations, operative method, operative time, conversion to open procedure, intraoperative and postoperative complications, and the presence of retained and recurrent stones. All patients were followed up for 3 years by telephone interview ang outpatient visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom appeared during the follow-up period. If there were unusual findings, magnetic resonance cholangiopancreatography(MRCP) was carried out.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with age between 18 - 80 years.
  • Patients diagnosed with gallstones.
  • Patients diagnosed with common bile duct stone by one of the three exam (MRI、MRCP and CT).
  • Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration.
  • Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).

排除标准

  • Combined with Mirizzi syndrome and intrahepatic bile duct stones
  • Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD)
  • History of upper abdominal surgery.
  • Serious heart,brain,lung, metabolic diseases history.
  • Pregnant women
  • Unwillingness or inability to consent for the study.

结局指标

主要结局

Rate of Adverse outcomes

时间窗: 3 years

The patients with complication / the total patients

次要结局

  • Hospital stay(3 years)
  • Stricture of the bile duct rate rate(3 years)
  • Operation time(3 years)
  • Bile leakage rate(30 days)
  • Mortality(3 years)
  • Perforation Rate(30 days)
  • Acute cholangitis rate(30 days)
  • Hemorrhage Rate(3 years)
  • Acute pancreatitis Rate(30 days)
  • Incremental cost-effectiveness ratio(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhongtao Zhang

Doctor

Beijing Friendship Hospital

研究点 (1)

Loading locations...

相似试验